1-[(9Z)-hexadecenyl]-2-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine

Metabolite details

Identifier

MZDGVRYVGYDNAO-KETLZHFASA-N

InChI Key

MZDGVRYVGYDNAO-KETLZHFASA-N

IUPAC name

(2R)-2-{[(9Z)-hexadec-9-enoyl]oxy}-3-{[(9Z)-hexadec-9-en-1-yl]oxy}propyl 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

1-[(9Z)-hexadecenyl]-2-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine

INN name

—

Synonym

PC(o-16:1(9Z)/16:1(9Z))

ChEBI

CHEBI:86425

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• Physiological extremes of the human blood metabolome: A metabolomics analysis of highly glycolytic, oxidative, and anabolic athletes
• Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• non_COVID_19_healthy_vs_non_critical_COVID_19
• Control_Baseline_vs_Control_Post-Exercise
• Mild_vs_Severe
• BSA_Control_vs_AA